Therefore, this study strongly encourages the targeting of STAT3 in anti-cancer therapy considering that, in addition to the inhibition of pro-survival molecules so far reported, our study suggests that STAT3 stabilizes mutp53 in cancer cells carrying mutp53 and activates wtp53 in cancer cells harboring wtp53. This evidence concerns the gene STAT3 and cancer.